Keyphrases
Academy
8%
Autoimmune Neuropathy
13%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
38%
Clinical Assessment
5%
Clinical Features
9%
Clinical Practice
8%
Demyelinating Neuropathy
7%
Diagnostic pitfalls
8%
Disability
17%
Disease Activity
6%
Disease Burden
7%
Efgartigimod
7%
Electrodiagnosis
11%
Global Survey
7%
Grip Strength
12%
Hizentra
11%
Hypereosinophilic Syndrome
11%
Immune Response
8%
Immunoglobulin
7%
Immunoglobulin G
8%
Inflammatory Neuropathy
12%
Intravenous Immunoglobulin (IVIg)
25%
Intravenous Immunoglobulin Therapy
6%
Joint Task
7%
Multifocal Motor Neuropathy
6%
Myasthenia Gravis
11%
Myelin-associated Glycoprotein
8%
Nerve
8%
Nerve Conduction Studies
10%
Neurologist
7%
Neurology
10%
Neuromuscular Medicine
7%
Neuropathy
28%
Peripheral Nerve
15%
Peripheral Nervous System
6%
Phase II Study
7%
Phase II Trial
7%
Placebo
13%
Placebo-controlled
12%
Plasmid DNA (pDNA)
7%
Polyneuropathy
12%
Quality of Life
5%
Randomized Double-blind
7%
Routine Care
7%
Society Guidelines
8%
Subcutaneous Immunoglobulin
13%
Tolerability
6%
Treatment Response
11%
Treatment-related Fluctuation
7%
Medicine and Dentistry
Amyotrophic Lateral Sclerosis
7%
Biological Marker
7%
Cerebrospinal Fluid
7%
Chronic Inflammatory Demyelinating Polyneuropathy
64%
Clinical Assessment
5%
Clinician
11%
Diagnostic Error
15%
Disease
5%
Disease Course
5%
Diseases
22%
Electrodiagnosis
8%
Eosinophilia Myalgia Syndrome
7%
Immunoglobulin
23%
Immunotherapy
9%
Maintenance Therapy
5%
Multifocal Motor Neuropathy
8%
Myelin Associated Glycoprotein
7%
Nerve Conduction Study
6%
Neurology
11%
Neuropathy
48%
Peripheral Nerve
12%
Placebo
11%
Polyneuropathy
10%
Polyradiculoneuropathy
27%
Treatment Response
10%
Tryptophan
5%